Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Zolpidem is a hypnotic benzodiazepine site agonist with some γ‐aminobutyric acid (GABA)A receptor subtype selectivity. Here, we have tested the effects of zolpidem on the hippocampus of γ2 subunit (γ2F77I) point mutant mice. Analysis of forebrain GABA A receptor expression with immunocytochemistry, quantitative [3 H]muscimol and [35 S] t‐butylbicyclophosphorothionate (TBPS) autoradiography, membrane binding with [3 H]flunitrazepam and [3 H]muscimol, and comparison of miniature inhibitory postsynaptic current (mIPSC) parameters did not reveal any differences between homozygous γ2I77/I77 and γ2F77/F77 mice. However, quantitative immunoblot analysis of γ2I77/I77 hippocampi showed some increased levels of γ2, α1, α4 and δ subunits, suggesting that differences between strains may exist in unassembled subunit levels, but not in assembled receptors. Zolpidem (1 µ m) enhanced the decay of mIPSCs in CA1 pyramidal cells of control (C57BL/6J, γ2F77/F77) mice by ∼ 60%, and peak amplitude by ∼ 20% at 33–34 °C in vitro. The actions of zolpidem (100 n m or 1 µ m) were substantially reduced in γ2I77/I77 mice, although residual effects included a 9% increase in decay and 5% decrease in peak amplitude. Similar results were observed in CA1 stratum oriens/alveus interneurons. At network level, the effect of zolpidem (10 µ m) on carbachol‐induced oscillations in the CA3 area of γ2I77/I77 mice was significantly different compared with controls. Thus, the γ2F77I point mutation virtually abolished the actions of zolpidem on GABA A receptors in the hippocampus. However, some residual effects of zolpidem may involve receptors that do not contain the γ2 subunit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whittington, M. A., Traub, R. D., & Jefferys, J. G. R. (1995) · Nature · doi:10.1038/373612a0 · Cited by 1,613 · cited 1×
“Actions of zolpidem on carbachol-induced oscillations in the CA3 area of c2I77 ⁄ I77 mice are attenuated Oscillatory activity in the beta ⁄ gamma frequency range is critically dependent on the rhythmic synchronous output of populations of interneurons (Whittington et al., 1995; Fisahn et al., 1998).”
BackgroundSynchronization of neuronal activity in hippocampus by individual GABAergic interneurons
Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., & Somogyi, P. (1995) · Nature · doi:10.1038/378075a0 · Cited by 1,498 · cited 1×
“Because rhythmic inhibitory synaptic potentials have a pivotal role in phasing the activity of pyramidal cells (Cobb et al., 1995), the prolongation of IPSCs alone may well explain the decrease in the frequency of oscillations.”
BackgroundSelf-citationBrain-state- and cell-type-specific firing of hippocampal interneurons in vivo
Klausberger, T., Magill, P. J., Márton, L. F., Roberts, J. D. B., Cobden, P. M., Buzsáki, G., & Somogyi, P. (2003) · Nature · doi:10.1038/nature01374 · Cited by 1,345 · cited 3×
“Interneurons phase the rhythmic activity of pyramidal neurons (Klausberger et al., 2003) during hippocampal-related behaviour (Csicsvari et al., 1999).”
BackgroundSelf-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving rat
Csicsvari, J., Hirase, H., Czurkó, A., Mamiya, A., & Buzsáki, G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00274.1999 · Cited by 966
Defined types of cortical interneurone structure space and spike timing in the hippocampus
Somogyi, P., & Klausberger, T. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.078915 · Cited by 927
Self-citationCholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro
Fisahn, A., Pike, F. G., Buhl, E. H., & Paulsen, O. (1998) · Nature · doi:10.1038/28179 · Cited by 884 · cited 5×
“Actions of zolpidem on carbachol-induced oscillations in the CA3 area of c2I77 ⁄ I77 mice are attenuated Oscillatory activity in the beta ⁄ gamma frequency range is critically dependent on the rhythmic synchronous output of populations of interneurons (Whittington et al., 1995; Fisahn et al., 1998).”
BackgroundInfluentialMcBain, C. J., & Fisahn, A. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049047 · Cited by 581
Gulyás, A. I., Hájos, N., & Freund, T. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03397.1996 · Cited by 512
Gao, B., & Fritschy, J. M. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00994.x · Cited by 147 · cited 3×
“The a1 subunit is expressed at high density in a subset of parvalbumin (PV)-positive interneurons (Gao & Fritschy, 1994), while the a3 subunit is preferentially expressed in a small population of SO ⁄A interneurons (Brünig et al., 2002).”
Background
Cited by
Wulff, P., Ponomarenko, A. A., Bartos, M., Korotkova, T. M., Fuchs, E. C., Bähner, F., Both, M., Tort, A. B. L., Kopell, N. J., Wisden, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813176106 · Cited by 400
Self-citationRemote Control of Neuronal Signaling
Rogan, S. C., & Roth, B. L. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003020 · Cited by 339
Postnatal Differentiation of Basket Cells from Slow to Fast Signaling Devices
Doischer, D., Aurel Hosp, J., Yanagawa, Y., Obata, K., Jonas, P., Vida, I., & Bartos, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2890-08.2008 · Cited by 248
How can drug discovery for psychiatric disorders be improved?
Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., et al. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2217 · Cited by 240
Self-citationBenzodiazepines compromise the outcome of cancer immunotherapy
Montégut, L., Derosa, L., Messaoudene, M., Chen, H., Lambertucci, F., Routy, B., Zitvogel, L., Martins, I., & Kroemer, G. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2413719 · Cited by 18
Metadata
- Authors
- Cope, D. W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A. ‐., Oberto, A., Ogris, W., Korpi, E. R., Sieghart, W., Somogyi, P., Wisden, W., & Capogna, M.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 21
- Issue
- 11
- Pages
- 3002-3016
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2103894607
- Cited by
- 39
- References
- 10
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation. https://app.cochat.ai/papers/10.1111/j.1460-9568.2005.04127.x
- The paper
- Cope, D. W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A. ‐., Oberto, A., Ogris, W., Korpi, E. R., Sieghart, W., Somogyi, P., Wisden, W., & Capogna, M. (2005). Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2005.04127.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.